GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Revenue

LTR Pharma (ASX:LTP) Revenue : A$0.06 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Revenue?

LTR Pharma's revenue for the six months ended in Dec. 2024 was A$0.06 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.06 Mil. LTR Pharma's Revenue per Share for the six months ended in Dec. 2024 was A$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


LTR Pharma Revenue Historical Data

The historical data trend for LTR Pharma's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Revenue Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Revenue
- - - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24
Revenue Get a 7-Day Free Trial - - - - 0.06

Competitive Comparison of LTR Pharma's Revenue

For the Biotechnology subindustry, LTR Pharma's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LTR Pharma's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Revenue distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Revenue falls into.



LTR Pharma Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LTR Pharma  (ASX:LTP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


LTR Pharma Revenue Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LTR Pharma Business Description

Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.

LTR Pharma Headlines

No Headlines